浙江医药：VE、VD3价格上涨带动公司盈利能力提升，医药业务稳健

Risks: Risk of changes in macroeconomic environment and geopolitics; risk of product price fluctuations; risk of lower-than-expected demand in downstream markets. ESG Comments Environmental: [Table_APPENDIX] 附录 APPENDIX [Table_disclaimer] HTIRL 分析师认证 Analyst Certification: 利益冲突披露 Conflict of Interest Disclosures 海通国际及其某些关联公司可从事投资银行业务和/或对本研究中的特定股票或公司进行做市或持有自营头寸。就本研究报告而言，以下是有关该等关系的披露事项（以下披露不能保 证及时无遗漏，如需了解及时全面信息，请发邮件至 ERD-Disclosure@htisec.com） HTI and some of its affiliates may engage in investment banking an ...